<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01459302</url>
  </required_header>
  <id_info>
    <org_study_id>H-13019</org_study_id>
    <secondary_id>5RC2NS070342-02</secondary_id>
    <nct_id>NCT01459302</nct_id>
  </id_info>
  <brief_title>Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders</brief_title>
  <official_title>Family Studies in Neuromuscular Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Worcester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Massachusetts, Worcester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators laboratory has been studying families with a history of ALS for more than
      25 years and is continuing to use new ways to understand how genes may play a role in ALS,
      motor neuron disease and other neuromuscular disorders.

      The purpose of this study is to identify additional genes that may cause or put a person at
      risk for either familial ALS (meaning 2 or more people in a family who have had ALS),
      sporadic ALS, or other forms of motor neuron disease in the hopes of improving diagnosis and
      treatment. As new genes are found that may be linked to ALS in families or individuals, the
      investigators can then further study how that gene may be contributing to the disease by
      studying it down to the protein and molecular level. This includes all forms of ALS, motor
      neuron disease and ALS with fronto-temporal dementia(ALS/FTD). We also continue to study
      other forms of neuromuscular disease such as Miyoshi myopathy, FSH dystrophy and other forms
      of muscular dystrophy by looking at the genes that may be associated with them.

      There have been a number of genes identified that are associated both familial and sporadic
      ALS, with the SOD1, C9orf72, and FUS genes explaining the majority of the cases. However, for
      about 30% of families with FALS, the gene(s) are still unknown.

      The investigators also will continue to work with families already identified to carry one of
      the known genes associated with ALS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be asked to provide a blood sample and to complete a couple of
      questionnaires regarding their overall medical health and some environmental risk factors.
      Medical records will be requested for all those diagnosed with one of the study diseases to
      allow the researchers to review details of their clinical disease symptoms, neurological
      exams and test results.

      Participants do not need to travel to Massachusetts for this study. Samples can be obtained
      locally at no costs to the participant. Family members may be included in the study depending
      on family history and their relationship to the affected individual.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>identification of new genes that may contribute to ALS</measure>
    <time_frame>Up to 9 years</time_frame>
    <description>identification and reporting of any new genes that may associated with individuals or families with ALS is a primary goal to provide better diagnostics as well as new targets for treatment.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <condition>Frontotemporal Dementia</condition>
  <condition>PLS</condition>
  <condition>Motor Neuron Disease</condition>
  <condition>Lou Gehrigs Disease</condition>
  <condition>Familial Disease</condition>
  <condition>Amyotrophic Lateral Sclerosis, Sporadic</condition>
  <condition>Muscular Dystrophy</condition>
  <condition>Miyoshi Myopathy</condition>
  <arm_group>
    <arm_group_label>Familial and Sporadic ALS</arm_group_label>
    <description>Individuals with ALS and families with a history of two or more people in the family who have had ALS or other forms of motor neuron disease.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA(plus Serum, frozen cells when available) will be obtained from the initial blood or
      saliva sample for genetic study. RNA, skin cells or lymphoblast cells may be obtained and
      stored.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals diagnosed with ALS, motor neuron disease, PLS, ALS with dementia, Miyoshi
        Myopathy, some muscular dystrophies and spouse/population controls. Some family members may
        be eligible to participate as well.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of or family history of ALS,MND,ALS with dementia, or PLS.

          -  diagnosis of Miyoshi myopathy

          -  willingness to provide a blood sample for study use

        Exclusion Criteria:

          -  unwilling to provide a blood or saliva sample
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert H Brown Jr., D Phil,MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>U Mass Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane McKenna-Yasek, RN BSN</last_name>
    <phone>508-856-4697</phone>
    <email>diane.mckenna-yasek@umassmed.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane M McKenna-Yasek, RN, BSN</last_name>
      <phone>508-856-4697</phone>
      <email>diane.mckenna-yasek@umassmed.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009 Feb 27;323(5918):1205-8. doi: 10.1126/science.1166066.</citation>
    <PMID>19251627</PMID>
  </results_reference>
  <results_reference>
    <citation>Shatunov A, Mok K, Newhouse S, Weale ME, Smith B, Vance C, Johnson L, Veldink JH, van Es MA, van den Berg LH, Robberecht W, Van Damme P, Hardiman O, Farmer AE, Lewis CM, Butler AW, Abel O, Andersen PM, Fogh I, Silani V, Chiò A, Traynor BJ, Melki J, Meininger V, Landers JE, McGuffin P, Glass JD, Pall H, Leigh PN, Hardy J, Brown RH Jr, Powell JF, Orrell RW, Morrison KE, Shaw PJ, Shaw CE, Al-Chalabi A. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 2010 Oct;9(10):986-94. doi: 10.1016/S1474-4422(10)70197-6. Erratum in: Lancet Neurol. 2011 Mar;10(3):205.</citation>
    <PMID>20801717</PMID>
  </results_reference>
  <results_reference>
    <citation>Blauw HM, Al-Chalabi A, Andersen PM, van Vught PW, Diekstra FP, van Es MA, Saris CG, Groen EJ, van Rheenen W, Koppers M, Van't Slot R, Strengman E, Estrada K, Rivadeneira F, Hofman A, Uitterlinden AG, Kiemeney LA, Vermeulen SH, Birve A, Waibel S, Meyer T, Cronin S, McLaughlin RL, Hardiman O, Sapp PC, Tobin MD, Wain LV, Tomik B, Slowik A, Lemmens R, Rujescu D, Schulte C, Gasser T, Brown RH Jr, Landers JE, Robberecht W, Ludolph AC, Ophoff RA, Veldink JH, van den Berg LH. A large genome scan for rare CNVs in amyotrophic lateral sclerosis. Hum Mol Genet. 2010 Oct 15;19(20):4091-9. doi: 10.1093/hmg/ddq323. Epub 2010 Aug 4.</citation>
    <PMID>20685689</PMID>
  </results_reference>
  <results_reference>
    <citation>Ticozzi N, LeClerc AL, Keagle PJ, Glass JD, Wills AM, van Blitterswijk M, Bosco DA, Rodriguez-Leyva I, Gellera C, Ratti A, Taroni F, McKenna-Yasek D, Sapp PC, Silani V, Furlong CE, Brown RH Jr, Landers JE. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol. 2010 Jul;68(1):102-7. doi: 10.1002/ana.21993.</citation>
    <PMID>20582942</PMID>
  </results_reference>
  <results_reference>
    <citation>van Es MA, Veldink JH, Saris CG, Blauw HM, van Vught PW, Birve A, Lemmens R, Schelhaas HJ, Groen EJ, Huisman MH, van der Kooi AJ, de Visser M, Dahlberg C, Estrada K, Rivadeneira F, Hofman A, Zwarts MJ, van Doormaal PT, Rujescu D, Strengman E, Giegling I, Muglia P, Tomik B, Slowik A, Uitterlinden AG, Hendrich C, Waibel S, Meyer T, Ludolph AC, Glass JD, Purcell S, Cichon S, Nöthen MM, Wichmann HE, Schreiber S, Vermeulen SH, Kiemeney LA, Wokke JH, Cronin S, McLaughlin RL, Hardiman O, Fumoto K, Pasterkamp RJ, Meininger V, Melki J, Leigh PN, Shaw CE, Landers JE, Al-Chalabi A, Brown RH Jr, Robberecht W, Andersen PM, Ophoff RA, van den Berg LH. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet. 2009 Oct;41(10):1083-7. doi: 10.1038/ng.442. Epub 2009 Sep 6.</citation>
    <PMID>19734901</PMID>
  </results_reference>
  <results_reference>
    <citation>Wu CH, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, Lowe P, Koppers M, McKenna-Yasek D, Baron DM, Kost JE, Gonzalez-Perez P, Fox AD, Adams J, Taroni F, Tiloca C, Leclerc AL, Chafe SC, Mangroo D, Moore MJ, Zitzewitz JA, Xu ZS, van den Berg LH, Glass JD, Siciliano G, Cirulli ET, Goldstein DB, Salachas F, Meininger V, Rossoll W, Ratti A, Gellera C, Bosco DA, Bassell GJ, Silani V, Drory VE, Brown RH Jr, Landers JE. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature. 2012 Aug 23;488(7412):499-503. doi: 10.1038/nature11280.</citation>
    <PMID>22801503</PMID>
  </results_reference>
  <results_reference>
    <citation>González-Pérez P, Cirulli ET, Drory VE, Dabby R, Nisipeanu P, Carasso RL, Sadeh M, Fox A, Festoff BW, Sapp PC, McKenna-Yasek D, Goldstein DB, Brown RH Jr, Blumen SC. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis. Neurology. 2012 Nov 27;79(22):2201-8. doi: 10.1212/WNL.0b013e318275963b. Epub 2012 Nov 14.</citation>
    <PMID>23152587</PMID>
  </results_reference>
  <results_reference>
    <citation>Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, Sapp PC, Silani V, Bosco DA, Shaw CE, Brown RH Jr, Landers JE. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):285-90. doi: 10.1002/ajmg.b.31158. Epub 2011 Jan 13.</citation>
    <PMID>21438137</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 21, 2011</study_first_submitted>
  <study_first_submitted_qc>October 24, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 25, 2011</study_first_posted>
  <last_update_submitted>August 30, 2017</last_update_submitted>
  <last_update_submitted_qc>August 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>FALS</keyword>
  <keyword>ALS</keyword>
  <keyword>SALS</keyword>
  <keyword>MND</keyword>
  <keyword>SOD1</keyword>
  <keyword>ALS GENES</keyword>
  <keyword>PLS</keyword>
  <keyword>PMA</keyword>
  <keyword>ALS/FTD</keyword>
  <keyword>FAMILIAL ALS</keyword>
  <keyword>SPORADIC ALS</keyword>
  <keyword>GENETICS</keyword>
  <keyword>FTD</keyword>
  <keyword>Miyoshi myopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Muscular Dystrophies</mesh_term>
    <mesh_term>Muscular Diseases</mesh_term>
    <mesh_term>Frontotemporal Dementia</mesh_term>
    <mesh_term>Aphasia, Primary Progressive</mesh_term>
    <mesh_term>Pick Disease of the Brain</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Distal Myopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

